• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析治疗期间卡托普利(SQ 14225)的清除率。

Captopril (SQ 14225) clearance during hemodialysis treatment.

作者信息

Hirakata H, Onoyama K, Iseki K, Omae T, Fujimi S, Kawahara Y

出版信息

Clin Nephrol. 1981 Dec;16(6):321-3.

PMID:7032776
Abstract

The clearance of Captopril (SQ 14225) was examined in six hemodialysis patients, using a newly developed method for the determination of Captopril in blood. At 30 minutes after the start of hemodialysis, the clearance of Captopril was 80 +/- 14.2 ml/min, whereas that of creatinine was 123.4 +/- 8.8 ml/min and that of BUN was 144.1 +/- 7.2 ml/min. The blood concentration of Captopril was found to be lower when taken in a postprandial state than in a fasting state.

摘要

使用一种新开发的血液中卡托普利测定方法,对6名血液透析患者的卡托普利(SQ 14225)清除率进行了检测。血液透析开始30分钟后,卡托普利的清除率为80±14.2毫升/分钟,而肌酐的清除率为123.4±8.8毫升/分钟,尿素氮的清除率为144.1±7.2毫升/分钟。发现卡托普利在餐后状态下摄入时的血药浓度低于空腹状态。

相似文献

1
Captopril (SQ 14225) clearance during hemodialysis treatment.血液透析治疗期间卡托普利(SQ 14225)的清除率。
Clin Nephrol. 1981 Dec;16(6):321-3.
2
Immediate hemodynamic response to SQ 14225 (Captopril) in hypertensive and normotensive hemodialysis patients.高血压和血压正常的血液透析患者对SQ 14225(卡托普利)的即时血流动力学反应。
Clin Nephrol. 1981 Sep;16(3):137-41.
3
[Pharmacodynamics of captopril (SQ 14225) in chronic renal failure (author's transl)].卡托普利(SQ 14225)在慢性肾功能衰竭中的药效学(作者译)
Nihon Jinzo Gakkai Shi. 1981 Oct;23(10):1319-26.
4
Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
Clin Nephrol. 1982 Mar;17(3):149-54.
5
Elimination kinetics of captopril in patients with renal failure.卡托普利在肾衰竭患者中的消除动力学。
Kidney Int. 1984 Jun;25(6):942-7. doi: 10.1038/ki.1984.114.
6
Severe side-effects of captopril in advanced chronic kidney insufficiency.
Proc Eur Dial Transplant Assoc. 1983;20:530-7.
7
Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure.慢性肾功能衰竭患者中卡托普利(SQ 14,225)的血药浓度及尿排泄情况。
Hypertension. 1981 Jul-Aug;3(4):456-9. doi: 10.1161/01.hyp.3.4.456.
8
Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
J Nephrol. 2004 Jan-Feb;17(1):101-6.
9
Cystatin C measurement and its practical use in patients with various renal diseases.胱抑素C检测及其在各种肾脏疾病患者中的实际应用。
Clin Nephrol. 1997 Aug;48(2):104-8.
10
Circulating type VI collagen and undulin, in patients with kidney diseases, after kidney transplantation and on hemodialysis.肾脏疾病患者、肾移植后患者及血液透析患者体内的循环VI型胶原蛋白和内屈蛋白。
Clin Nephrol. 1995 Sep;44(3):178-84.

引用本文的文献

1
Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.血管紧张素拮抗剂与血管紧张素转换酶抑制剂在终末期肾病中的风险效益比
Drug Saf. 2000 May;22(5):350-60. doi: 10.2165/00002018-200022050-00003.
2
Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.血管紧张素转换酶(ACE)抑制剂在肾衰竭患者中的临床药代动力学
Clin Pharmacokinet. 1993 Mar;24(3):230-54. doi: 10.2165/00003088-199324030-00005.
3
Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
卡托普利:关于其药理特性及在充血性心力衰竭中治疗效果的最新综述
Drugs. 1983 Jan;25(1):6-40. doi: 10.2165/00003495-198325010-00002.
4
Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.卡托普利在健康受试者和心血管疾病患者中的药代动力学。
Clin Pharmacokinet. 1988 Apr;14(4):241-59. doi: 10.2165/00003088-198814040-00002.
5
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.卡托普利。其药效学和药代动力学特性的最新进展,以及在高血压和充血性心力衰竭中的治疗应用。
Drugs. 1988 Nov;36(5):540-600. doi: 10.2165/00003495-198836050-00003.
6
Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.血管紧张素转换酶抑制剂的临床药代动力学。综述。
Clin Pharmacokinet. 1985 Sep-Oct;10(5):377-91. doi: 10.2165/00003088-198510050-00001.